All Activity

Taking advantage of the exciting chance given by Monkey Market to build your own store from the bottom up will test your managerial skills and creative insight.

Dordle is an exceptional game to have available, whether you are feeling discontent, exhausted, or only require a reminder of life's pleasures.

I have acquired numerous new vocabulary terms from Quordle. It is an excellent technique for acquiring new lexicon and enhancing my vocabulary.

That's awesome to see women taking charge in Southern Oregon's cannabis scene! It sounds like Tokeativity's expansion will bring a lot of positive energy and opportunities for connection. Reminds me of how some online communities thrive through shared experiences and friendly competition, like you find in Flappy Bird. It's all about building something together and having fun along the way.

It is a good site post without fail. Not too many people would actually, the way you just did. I am impressed that there is so much information about this subject that has been uncovered and you’ve defeated yourself this time, with so much quality. Good Works! 성인 피시방

Georgia’s governor has signed a bill to expand medical marijuana access in the state. SB 220, which Gov. Brian Kemp (R) approved on Tuesday, will add new qualifying conditions for the program, allow patients to vaporize medical cannabis and change THC potency limits, among other reforms. Under the legislation, patients with lupus will be allowed to legally access medical marijuana, building on the state’s current law that allows certain people with cancer, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, ALS, autism spectrum disorder, intractable pain and other conditions to qualify. The bill from Sen. Matt Brass (R) also removes the requirement for many conditions that the patient’s status be severe or end-stage to be allowed to enter the medical cannabis program. The reform will also expand how patients can use medical marijuana. Until now, they have been able to access oils, tinctures, capsules, lozenges, topicals and transdermal patches—but the new law will also allow vaping as delivery method for patients over 21 years of age, while continuing to prohibit smoking for all patients. The Putting Georgia’s Patients First Act additionally replaces the current 5 percent THC potency cap for medical cannabis products with a limit of 12,000 milligrams of THC that a patient can possess at any one time. “These changes, while meaningful to the affected patients, do not materially alter where Georgia sits in the national landscape on this issue,” Kemp said in a signing statement. “This bill passed with a constitutional majority in both chambers of the General Assembly.” “I, like many of those who expressed opposition to this bill, have reservations about the legalization of recreational cannabis. Many states that have legalized recreational cannabis have come to regret that decision,” he said. “I also recognize that for some patients, medical cannabis provides significant relief to symptoms that would otherwise go untreated or would be treated with even more harmful opioids.” “I do not believe that a well-implemented medical cannabis program must inevitably lead to the legalization of recreational use in Georgia, nor is the question of recreational use anywhere in the bill on my desk for signature,” the governor said. The bill also replaces references to “low THC oil” in current law with “medical cannabis.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The Georgia Access to Medical Cannabis Commission, which oversees the program, will get a new duty of conducting public awareness activities about “effective uses of medical cannabis and products, including, but not limited to, publishing materials and conducting outreach and public education activities to inform members of the public, law enforcement, and healthcare providers about the medical cannabis program in this state and the potential benefits that medical cannabis and products may have to eligible patients.” Last year, House leaders created a Blue-Ribbon Study Committee on Georgia’s Medical Marijuana and Hemp Policies to examine the state’s cannabis laws. Lawmakers in Georgia have also considered legislation to support research on the therapeutic benefits of psychedelics. The post Georgia Governor Signs Bill To Expand Medical Marijuana Access By Allowing Vaping And Adding New Qualifying Conditions appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A powerful congressional committee is allowing an amendment that would let military veterans receive recommendations for medical marijuana through their doctors at the Department of Veterans Affairs (VA) to advance to a vote on the House floor. The proposal from Reps. Brian Mast (R-FL), Dave Joyce (R-OH) and Dina Titus (D-NV), if enacted, would prevent VA from enforcing a longstanding directive that has blocked its providers from assisting veterans with registering for state medical cannabis programs. Under current policy, VA doctors can discuss marijuana use with their patients, but they cannot fill out forms to help them actually get legal access to cannabis. As a result, veterans need to seek outside, often expensive, services from separate providers instead of just being able to get assistance from their own doctors at VA. That would change under the new amendment from the co-chairs of the Congressional Cannabis Caucus, which is being offered to the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act. The House Rules Committee on Tuesday determined that the proposal can be considered in floor votes, expected later this week. The veterans medical marijuana amendment reads: “SEC. __. None of the funds appropriated or otherwise made available to the Department of Veterans Affairs in this Act may be used to enforce Veterans Health Directive 1315 as it relates to— (1) the policy stating that ‘VHA providers are prohibited from completing forms or registering Veterans for participation in a State-approved marijuana program’; (2) the directive for the ‘Deputy Under Secretary for Health for Operations and Management’ to ensure that ‘medical facility Directors are aware that it is VHA policy for providers to assess Veteran use of marijuana but providers are prohibited from recommending, making referrals to or completing paperwork for Veteran participation in State marijuana programs’; and (3) the directive for the ‘VA Medical Facility Director’ to ensure that ‘VA facility staff are aware of the following’ ‘[t]he prohibition on recommending, making referrals to or completing forms and registering Veterans for participation in State-approved marijuana programs.'” While similar proposals on veterans’ medical marijuana access have been passed by both the House of Representatives and Senate in past years, they have never been enacted into law. Last year, when the House- and Senate-passed language was left out of the final bill sent to President Donald Trump, Mast told Marijuana Moment that the exclusion was “ridiculous.” “It was a great and easy opportunity to do so, and a sensical thing to move forward—and detrimental to veterans to not do so,” he said. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The current amendment comes just weeks after medical marijuana was rescheduled under federal law by the Trump administration, a major policy and political development that advocates hope could boost the chances of the veterans-focused reform being enacted this year. A separate amendment to the military and veterans spending bill that the Rules Committee is also allowing to receive a floor vote seeks to raise awareness about the benefits of psychedelic and other therapies for military veterans. Sponsored by Reps. Lou Correa (D-CA) and Jack Bergman (R-MI), who co-chair the Congressional Psychedelics Advancing Therapies Caucus, the amendment’s description says it “increases and decreases funding for the Medical and Prosthetic Research account at the Department of Veterans Affairs to emphasize the importance of the Department’s research on areas benefiting veterans such as oncology, traumatic brain injury care, psychedelic therapies, and assistive devices.” Meanwhile in Congress, the House Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies approved a bill last month containing provisions that would block federal officials from taking further steps to reschedule cannabis. Separately, the House Appropriations Committee approved a spending bill and an attached report that expresses concerns about health risks from cannabis-derived products, while also encouraging research into the therapeutic benefits of psychedelics. The full House also recently passed a Farm Bill with provisions aimed at aiding industrial hemp producers—but without any language to delay or alter the federal recriminalization of hemp THC products that’s scheduled to take effect later this year. A new report from the Congressional Research Service details the scope and limitations of the federal marijuana rescheduling move. The post Congressional Amendment To Let Military Veterans Get Medical Marijuana Recommendations Through The VA Advances To Floor Vote appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Thanks for sharing this valuable post. The information is clear, useful, and easy to follow. I really appreciate the effort, Best iptv

“This bill is more than a policy change—it offers real hope to so many people who desperately need it.” By Jack Gorsline, Filter The Oklahoma State Senate voted on April 29 to pass the Oklahoma Breakthrough Therapy Act. Formally known as House Bill 3834, the measure authorizes the use of state funds to support trials focused on ibogaine—the powerful, naturally occurring psychedelic compound. The bill passed the House in March. If signed into law by Governor Kevin Stitt (R), it will mark a significant shift in Oklahoma’s approach to the ongoing crises around mental health and substance use disorders. It would authorize the State Department of Health to enter into contracts with drug developers to conduct extensive, state-monitored clinical trials for ibogaine-based therapeutics. Lawmakers who championed the bill argue that traditional treatment methods have consistently fallen short, necessitating a research-driven exploration of breakthrough therapies. The legislation is also designed to facilitate collaboration with other states currently conducting similar clinical research, creating a multistate consortium aimed at securing federal regulatory approval. Ibogaine is derived from the root bark of the iboga shrub. For decades, the compound has shown observational promise in interrupting severe substance use disorders—particularly opioids—and alleviating post-traumatic stress disorder and traumatic brain injuries. However, because ibogaine is federally classified as a Schedule I controlled substance, it remains illegal to possess, distribute or administer outside of highly restricted research settings. This has seen desperate patients seek unregulated and costly treatments abroad. Ibogaine use for these purposes is not without controversy or risk. There are well-documented medical hazards, most notably the potential for severe cardiac complications, which have led to efforts to develop safer versions of the compound. There are also risks around resumed opioid use with lowered tolerance if ibogaine is used for withdrawal and abstinence. Recognizing these issues, proponents of the Oklahoma bill stress that state-sponsored clinical trials would bring the treatment out of the unregulated shadows and into highly controlled medical environments. Under the proposed framework, patients would undergo rigorous pre-treatment medical evaluations and receive the drug under continuous monitoring by medical professionals. To mitigate financial risk to the state and seek a high standard of research, the bill imposes requirements on participating drug developers. Any drug developer contracting with the health department would have to match the state’s financial investment in the trials dollar-for-dollar Developers would additionally be required to submit a detailed plan for obtaining approval from the U.S. Food and Drug Administration (FDA), along with protocols for trial participant recruitment, patient screening criteria, safety and post-acute treatment support. The bill also mandates that drug developers prioritize treatment access for Oklahoma residents once FDA approval is secured. And the legislation requires a plan to protect the state’s economic interest in any intellectual property generated. The idea is that if the trials yield a profitable, FDA-approved therapeutic, funds will come back to the state. The legislation establishes a dedicated revolving fund to capture any proceeds. By law, this money could only be utilized for programs or further research that directly benefit at-risk Oklahomans with conditions treatable by ibogaine. The bill grants medical professionals professional immunity too, shielding them from adverse licensing actions by state medical boards for recommending these trials to their patients. The passage of House Bill 3834 through the Senate represents a major victory for a coalition of patient advocates, veterans and others. These groups have spent months sharing deeply personal stories of addiction, trauma and recovery with state lawmakers, aiming to demystify ibogaine and highlight its potential. “Oklahoma for Ibogaine is celebrating the passing of HB 3834 through the Senate,” Nate Morgans, an Oklahoma-based psychedelics advocate and CEO of the Casey Skudin 343 Fund, told Filter. “Our team has worked tirelessly since December to educate, inform, and persuade Oklahoma legislators on the importance of authorizing and funding FDA clinical trials of Ibogaine. This initiative was led by a grassroots effort, employed no lobbyists, and focused on education through truly lived experiences. Our success today serves as a testament to what can be accomplished with determined hearts.” In recent months, other state legislatures have begun viewing ibogaine research as a pragmatic health care response. In March, for instance, Mississippi Gov. Tate Reeves (R) signed similar legislation. The Mississippi law authorizes the state to form a consortium to conduct ibogaine clinical trials in direct coordination with other participating states—most notably neighboring Texas, which has already committed substantial funding to psychedelic research. While Mississippi’s new law establishes the legal and administrative framework for the clinical trials, the new law does not currently appropriate state general funds toward the program. However, state lawmakers have indicated their intent to allocate a portion of the state’s federal opioid settlement funds to support the initiative. Advocates are divided over such uses of money that could otherwise be funding under-resourced harm reduction efforts. State efforts to establish ibogaine clinical trials have not been uniformly successful. In April, a similar bill in West Virginia was derailed, after Gov. Patrick Morrisey (R) vetoed it. The bill would have established a state grant program to fund ibogaine drug development trials. It passed the state legislature, but Morrisey cited fiscal concerns in his veto message. Before killing the bill in the hours leading up to the state’s legislative deadline, he said that while he supports this medical innovation in principle, “we should do so without requiring the state to award grants of undefined and unfunded amounts.” Despite such setbacks and controversies, advocates for ibogaine access and development remain optimistic about growing national momentum. “This bill is more than a policy change—it offers real hope to so many people who desperately need it,” Chase Rowan told Filter of the Oklahoma bill. A US Army Ranger veteran, Rowan serves as both the veteran coordinator for Texans for Greater Mental Health and the director of Community Engagement & Advocacy for Americans for Ibogaine. It’s a development that will “offer hope” to veterans and their families, including those impacted by substance use disorders, he said, and who have “tried every conventional method known to man, with no success.” “Hello, Ibogaine, now we have an answer,” Rowan continued, “a real legitimate answer, something we can study, a medicine that will help so many people find true healing. Exciting things to come in the world of healing.” The Oklahoma Breakthrough Therapy Act now heads to Stitt’s desk, where it remains to be seen if it will be signed into law. This article was originally published by Filter, an online magazine covering drug use, drug policy and human rights through a harm reduction lens. Follow Filter on Bluesky, X or Facebook, and sign up for its newsletter. Photo courtesy of Flickr/Scamperdale. The post Oklahoma Lawmakers Pass Ibogaine Bill, Sending Psychedelic Reform To Governor’s Desk appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The California Assembly has passed a bill that would allow marijuana retailers to offer drive-thru windows to serve customers. The measure, which was approved in a floor vote of 55-9 on Monday, says that licensed cannabis retailers and microbusinesses with storefronts could sell marijuana products “to a customer in a motor vehicle in a drive-through located on the premises.” It previously cleared the Assembly Appropriations Committee and Business and Professions Committee, and next heads to the Senate for consideration. Under AB 2697 from Assemblymember Gail Pellerin (D), cannabis businesses would need approval from the local jurisdictions in which they operate in order to add the drive-thru option. The sponsor said on the floor that the bill “will expand access to legal cannabis products while strengthening legal market’s ability to compete with the illicit market.” Pellerin and supporters have testified that the legislation will help make legal cannabis more accessible, especially for medical patients who may find it difficult to get out of their cars. “California cannabis retailers lack a common and accessible transaction path for consumers afforded so many other retailers in California, including fast food, pharmacies, banks and even liquor stores,” Pellerin previously said. “Cannabis consumers who have mobility issues or other disabilities have limited options for being able to obtain cannabis without having to step out of their vehicles. And while home delivery is legal, there are service area restrictions,” she said. “Allowing cannabis retailers to add the consumer-friendly option of a secured drive through, if approved by the local jurisdiction, will enhance the consumer experience, increase safety at cannabis retailers, and help expand California’s legal cannabis marketplace.” The California Narcotic Officers’ Association opposes the proposal, however, arguing that “while intended to promote convenience, this retail model introduces elevated risks related to impaired driving, regulatory compliance, crime exposure, and traffic safety.” “Importantly, no similar statute authorizes drive-thru window liquor sales. Drive-thru window cannabis sales create a direct nexus between purchase and vehicle operations,” the police group said. “This will increase the likelihood of drug-impaired driving incidents and deaths by encouraging the immediate or near-immediate consumption following the purchase of edible and high-potency products resulting in dangerous impairment.” Under a current policy enacted during the height of the COVID pandemic, dispensaries can already offer curbside pickup. The bill that is advancing in the legislature would mandate that drive-thru sales “shall occur through a fixed-pane security window with a security drawer or similar secure transfer mechanism that is part of a building located within the premises.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — California regulators recently adopted changes to the state’s marijuana licensing process that are intended to make it easier for businesses to qualify for benefits in line with the Trump administration’s recent move to federally reschedule medical cannabis. Gov. Gavin Newsom (D), meanwhile, recently took credit for helping to lead the push for the state to legalize marijuana and discussed his own limited experience with using cannabis. In October, however, Newsom vetoed a bill that would have allowed certain marijuana microbusinesses to ship medical cannabis products directly to patients via common carriers like FedEx and UPS, stating that the proposal “would be burdensome and overly complex to administer.” Newsom did sign a bill earlier that month aimed at streamlining research on marijuana and psychedelics. In September, the governor also signed a measure into law to put a pause on a recently enacted tax hike on marijuana products. California officials recently awarded nearly $30 million in grants for marijuana-focused academic research projects. The post California Assembly Passes Bill To Legalize Marijuana Dispensary Drive-Thru Windows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

If board members object to a federal change, they must publicly issue their reasons and allow for a hearing process before any state action moves forward. By Casey Smith, Indiana Capital Chronicle Indiana lawmakers could soon revisit debates over medical marijuana legalization, but state officials say it remains unclear when—or if—federal marijuana reclassification will formally trigger action in Indiana. At a Monday meeting, the Indiana Board of Pharmacy reviewed a federal notice related to marijuana rescheduling but took no formal action. Board members said any future state response depends on the federal process becoming official. That means Indiana’s marijuana laws remain unchanged, for now. Even so, Republican Sen. Mike Bohacek announced on Monday his plans to draft 2027 legislation that would legalize medical marijuana in Indiana and establish regulations governing its sale, distribution and use. Bills for the 2027 session can’t be filed until later this year. “In light of the governor’s openness to consider legislation regarding the legalization of marijuana, we need to consider a feasible marijuana policy that would be the most helpful to Hoosiers and the economy,” Bohacek, of Michiana Shores, said in a statement. “The use of medical marijuana has been proven to be beneficial for some medical disorders and could help people throughout the state who are suffering find some relief.” The senator said his proposal would legalize medical marijuana, establish rules for medical use, create a tax structure for marijuana sales and distribution and update Indiana’s impairment laws related to THC use. The announcement sets up another likely marijuana debate at the Statehouse after years of failed efforts to loosen Indiana’s cannabis laws. Gov. Mike Braun (R) last month also signaled openness to broader discussions about marijuana legalization and regulation in Indiana. The governor stopped short of endorsing full legalization but said he was open to reviewing policy recommendations and hearing proposals from lawmakers on how Indiana should approach marijuana regulation moving forward. Although the U.S. Department of Justice last month announced limited Schedule III reclassification for certain state-licensed medical marijuana products, broader federal marijuana rescheduling remains tied up in an ongoing Drug Enforcement Administration process that has not yet been finalized. Federal hearings on broader rescheduling are scheduled to begin in June. The proposed federal change would move state-approved medical marijuana from Schedule I—reserved for drugs with no accepted medical use—to Schedule III, a less restrictive category that recognizes some medical uses. Leif Johnson, a lawyer for the state pharmacy board, said Monday that Indiana law requires the board to review any finalized federal scheduling change and determine whether the state will object to adopting similar changes under Indiana law. Under Indiana Code, the pharmacy board is tasked with reviewing controlled-substance scheduling changes and recommending whether the state should adopt comparable classifications. If board members object to a federal change, they must publicly issue their reasons and allow for a hearing process before any state action moves forward. Indiana remains among a shrinking number of states without a medical marijuana program, even as neighboring states have expanded legalization efforts. Multiple proposals to legalize or decriminalize marijuana—including limited medical-use bills—have repeatedly stalled in the General Assembly in recent legislative sessions. Earlier this year, Indiana lawmakers again failed to reach agreement on cannabis-related policy changes. A Senate-approved proposal to crack down on intoxicating hemp-derived THC products died before the legislature adjourned. Bohacek emphasized that his bill would not legalize recreational marijuana, though. “While the legislation I plan to propose would legalize the use of medical marijuana, it would not take away from the safety standards that would need to be established to keep Hoosiers safe,” he said. “This proposed legislation would not legalize the use of recreational marijuana.” Bohacek additionally said he plans to build “plenty of parameters” into the legislation governing how medical marijuana would be distributed and regulated in Indiana. “I intend to include plenty of parameters around the implementation and use of medical marijuana to ensure it’s being properly regulated and distributed by Hoosier healthcare professionals,” Bohacek said. He maintained that the legislation would establish THC impairment standards and additional law enforcement training requirements. “Many of our state’s current laws regarding the use of marijuana would remain in place, with some adjustments to account for those who may have medical exemptions,” Bohacek said. The senator argued, too, that Indiana should consider regulating and taxing marijuana products already widely available in the state. “Indiana has already allowed the sale of delta-8 THC and other similar cannabinoids, so creating a tax policy is a logical next step in expanding the use of THC products,” Bohacek said. “There is potential to bring in millions of dollars in tax revenue every year.” This story was first published by Indiana Capital Chronicle. The post Indiana Board Of Pharmacy Discusses Federal Marijuana Rescheduling’s Impact On State Policy appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A powerful congressional committee is expected to approve a report this week that directs federal officials to take enforcement action against unregulated cannabinoid products that “threaten consumer safety.” The House Appropriations Committee on Wednesday is set to take up a Fiscal Year 2027 spending bill covering Commerce, Justice, Science, and Related Agencies, as well as an attached report that includes the directive. It calls on the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) to address the “proliferation of Federally unregulated ingestible, inhalable, and topical products that contain intoxicating cannabinoids.” “Intoxicating Cannabidiols.—The Committee is concerned by the proliferation of Federally unregulated ingestible, inhalable, and topical products that contain intoxicating cannabinoids. The Committee directs the DEA, in coordination with the FDA Office of Inspections and Investigations, to take appropriate enforcement actions against those whose products threaten consumer safety and fail to meet the statutory definition of section 10113 of Public Law 115–334 and section 781 of Public Law 119–37. The Committee further directs the DEA to report on these efforts and any resources necessary to enforce the controlled substance laws and regulations of the United States not later than 90 days after the enactment of this Act.” While the provision doesn’t use the word “hemp,” it cites statutes covering the crop and appears responsive to widespread sales of products derived from it after they became legal under the 2018 Farm Bill. Congress has since passed, however, and President Donald Trump has signed, new legislation that will broadly recriminalize hemp THC products starting in November. The new appropriations report, meanwhile, also calls on the Department of Justice to take action against “money laundering schemes” tied to Chinese-connected illegal marijuana grow operations within the U.S. “Chinese Communist Party (CCP) Money Laundering.—The Committee directs the Department to utilize funds directed to anti-money laundering programs to investigate potential money laundering schemes involving CCP-connected marijuana businesses and entities providing financial services to these businesses.” Finally, the report notes that funding is being set aside for the Bureau of Prisons (BOP) to monitor wastewater to detect use of synthetic cannabinoids and other drugs by incarcerated people. “Wastewater Surveillance Pilot.—The Committee provides $8,500,000 to BOP to carry out a pilot program using a wastewater surveillance system to monitor the prevalence of infectious diseases—including Hepatitis C, HIV, tuberculosis, and respiratory pathogens—as well as the use of covered drugs, including fentanyl, nitazenes, and other synthetic opioids, methamphetamine, synthetic cannabinoids, and other controlled substances, among the incarcerated population at not fewer than six Federal correctional institutions. Sites will be selected to ensure representation across security classification levels, geographic regions of the United States, and institutional population sizes. Not later than 180 days after the completion of the pilot program, BOP shall submit a report detailing findings regarding the prevalence of infectious diseases and covered drug use at participating institutions, along with recommendations for legislative or administrative action.” The underlying spending legislation that the report is attached to, meanwhile, contains a provision to block federal officials from taking further steps to reschedule cannabis. It also includes an updated version of a longstanding rider that since 2014 has protected state medical cannabis programs from federal interference. The House Appropriations Committee last month approved a separate spending bill and an attached report that expresses concerns about health risks from cannabis-derived products, while also encouraging research into the therapeutic benefits of psychedelics. The full House also recently passed a Farm Bill with provisions aimed at aiding industrial hemp producers—but without any language to delay or alter the federal recriminalization of hemp THC products that’s scheduled to take effect later this year. The House Rules Committee is considering an amendment this week that would allow military veterans to receive recommendations for medical marijuana through their doctors at the Department of Veterans Affairs (VA). A new report from the Congressional Research Service details the scope and limitations of the federal marijuana rescheduling move. The post Congressional Committee Directs DEA To Crack Down On Unregulated Cannabis Products That ‘Threaten Consumer Safety’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I cannot wait to dig deep and kickoff utilizing resources that I received from you. Your exuberance is refreshing. 성인 피시방

Ohio officials are launching a public education campaign about the risks of marijuana use—an effort that involves partnering with an organization behind a new poll that shows widespread support for legalization and broad acceptance of cannabis use among the state’s residents. Ohio Gov. Mike DeWine (R) touted the campaign, which will be overseen by the Department of Commerce (DOC) and supported by $20 million appropriated by lawmakers under the state’s marijuana law, on Monday. DOC will collaborate with the OneOhio Recovery Foundation on the awareness initiative. “Since my first day in office, combating addiction and protecting the health of Ohio families has been a top priority for our administration,” DeWine said in a press release. “With non-medical marijuana now legal in Ohio, it’s more important than ever that Ohioans—especially young people and mothers—have access to accurate information and understand the real consequences of use.” While state officials pointed to recent polling from the OneOhio Recovery Foundation to justify the outreach effort—noting findings that show increase use of cannabis among adults since non-medical sales started in 2024, for example—the survey also included several takeaways underscoring public support for the reform. For example, 60 percent of Ohioans agreed that legalization “has been good for local communities,” compared to just 17 percent who disagreed. Another 53 percent “believe that their community would be better off if more adults used marijuana on a regular basis,” the polling report says. All told, about 2 in 5 Ohio adults (41 percent) said they consume cannabis in some form, including 56 percent of those under 55 years old. “Ohioans believe that using marijuana is relatively safe and is more acceptable now that it is legal,” the report from Public Opinion Strategies says, with 62 percent of Ohioans believing cannabis is a “relatively innocent drug that poses few risks to users” compared to other drugs. Among current cannabis consumers, 81 percent said the same. “Not only do 59 percent of Ohioans believe that recreational marijuana usage is safe, but 67 percent of all Ohioans agree that since marijuana is legal to use in the state, it is now more acceptable to use it,” the foundation’s survey found. “Ohioans just don’t believe that marijuana poses significant risks to its users.” “Reinforcing that finding, nearly 60 percent of Ohioans believe that recreational marijuana usage is safe. Fully 68 percent of marijuana users in the state agree that ‘using marijuana poses very little risk to my health.’ Likewise, most current marijuana users believe that marijuana usage has a positive effect on most people.” Men were more likely to report using marijuana (49 percent) than women (34 percent). Rates of usage were largely equitable across education levels, with 42 percent of high school graduates, 39 percent of those with some college experience and 43 percent of college graduates reporting cannabis consumption. Ohioans living in what the pollster described as “big” cities were about twice as likely to use marijuana (69 percent) than those living in more rural areas of the state (35 percent). Partnering with @1OhioFoundation, we’re launching a new statewide campaign to help Ohioans understand the health and safety risks of marijuana use. We’re starting with a maternal health focus and expanding through multi channel outreach. Learn more: https://t.co/k2As2KeC5C pic.twitter.com/BIfUBa1MLb — Ohio Commerce (@OhioCommerce) May 11, 2026 The survey involved interviews with 2,000 Ohio adults from February 23-March 1, with a +/-2.5 percentage point margin of error. The OneOhio Recovery Foundation, which commissioned the poll, says it was “created at the direction of Ohio’s state and local leaders to distribute 55 percent of the funds our state will receive from the pharmaceutical industry as a consequence of its role in the national opioid epidemic.” The organization’s board includes members appointed by the governor and attorney general, as well as leaders of the Senate and House of Representatives. Despite the widespread support for legalization and belief in the relatively safety of cannabis demonstrated by the survey, DeWine’s administration is promoting the partnership opportunity with the foundation as it gears-up for what it described as a “coordinated, multi-channel outreach effort to deliver clear, evidence-based information to Ohioans.” The first phase of the effort, which is set to launch this summer, will focus on promoting information about the health risks of using marijuana in the context of maternal health. That will be expanded to promote awareness around marijuana and youth—with paid media, community partnerships and “on-the-ground outreach coordinated by the Foundation.” OneOhio Recovery Foundation Executive Director Alisha Nelson said the organization is “seeing growing misconceptions about the risks associated with marijuana, and this campaign responds directly to what the research is telling us.” “Too many people underestimate those risks, especially for young people and during pregnancy,” Nelson said. “This effort is about ensuring Ohioans have clear, accurate information to protect their health and make informed decisions to safeguard their futures.” “As we recognize Maternal Health Awareness Month in May, we are preparing to launch a campaign that meets moms-to-be with information they can trust. Our goal is to help expectant mothers understand the risks of marijuana use during pregnancy, encourage open conversations with healthcare providers and connect families with resources to support healthy decisions.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile in Ohio, a law recently took effect undermining certain marijuana rules under the state’s voter-approved legalization statute, as well as rules for intoxicating hemp cannabinoid products. But the new law continues to be contested by cannabis businesses in court. Photo courtesy of Mike Latimer. The post Most Ohioans See Marijuana As ‘Safe’ And ‘Acceptable,’ New Poll Shows As State Officials Launch Campaign Highlighting Risks Of Use appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Engage with our escorts in Chawri Bazar. You can enjoy the most rewarding sexual experiences with our alluring girls. Our Escort Service in Chawri Bazar do not include veiling. You can find high-quality women for companionship. We are open to discussing your sexual desires. Reach out to us today for the most unique enjoyable experience at a budget-friendly rate.

زيادة لايكات فيسبوك تساعد في تحسين تفاعل المنشورات وزيادة انتشارها بين المستخدمين. كلما ارتفع عدد الإعجابات، زادت فرص وصول المحتوى إلى جمهور أكبر. كما تعزز هذه الزيادة مصداقية الصفحة وتدعم العلامات التجارية وصناع المحتوى في بناء حضور أقوى وتحقيق نمو أسرع على منصة فيسبوك بشكل ملحوظ. زيادة لايكات فيسبوك

Pretty good post. I just stumbled upon your blog and wanted to say that I have really enjoyed reading your blog posts. Any way I'll be subscribing to your feed and I hope you post again soon. Big thanks for the useful info. Woodlands trash bin cleaning

Iowa lawmakers have sent the governor legislation that would double the number of medical cannabis dispensaries that are allowed to operate in the state. Under current law, Iowa’s limited medical marijuana program allows only five dispensaries. That would double to 10 under HF 990, which was approved by the House of Representatives in an 88-5 vote last month and previously cleared the Senate in a tally of 42-5. The bill is now before Gov. Kim Reynolds (R), who can sign or veto it, or allow it to become law without her signature. Bridget Spiddle, public policy and communications coordinator for the Marijuana Policy Project (MPP), wrote in an action alert to supporters that the reform “would be a vital step in expanding medical cannabis access for one of the most restrictive medical cannabis programs in the country.” “No other medication gets treated like cannabis does. Pharmacies are widely accessible throughout Iowa, while dispensaries are capped at five locations for thousands of patients,” she said. “Rural Iowans have to expend enormous amounts of time and resources on costly travel to receive their medicine.” In addition to doubling the dispensary allowance, the proposal before the governor would also allow out-of-state residents to register in the medical cannabis program if they have a certification from an Iowa healthcare provider. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The Iowa Medical Cannabidiol Board, which oversees the state’s medical marijuana program, recommended in a 2023 report that the state allow more licenses “in an effort to provide Iowans with greater geographical access to medical cannabis products.” Under the program, patients with certain conditions can obtain cannabis products containing no more than at 4.5 grams of THC every 90 days. Flower and smoking are not allowed. Healthcare practitioners can allow greater amounts of THC for patients who are terminally ill or who have experience with the program and for whom the provider believes 4.5 grams is not enough. Separately this session, Iowa lawmakers are considering a bill to create a state-regulated therapeutic psilocybin program for patients with post-traumatic stress disorder (PTSD). Last year, the governor vetoed separate legislation that would have allowed doctors in the state to immediately prescribe a synthetic form of psilocybin in the event of federal approval of the psychedelic substance by the U.S. Food and Drug Administration (FDA), arguing that it “surrenders state authority to make an informed determination about classification to federal officials.” Photo courtesy of Kimzy Nanney. The post Iowa Bill To Double The Number Of Medical Marijuana Dispensaries Heads To Governor’s Desk appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I am glad you take pride in what you write. This makes you stand way out from many other writers that push poorly written content. 성인 피시방

This particular is usually apparently essential and moreover outstanding truth along with for sure fair-minded and moreover admittedly useful My business is looking to find in advance designed for this specific useful stuffs… fujiwin88

ATF changes marijuana question on gun form; MA lawmakers pass on anti-cannabis measure; CT psychedelics bill to gov; IN GOP legalization bill Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The Drug Enforcement Administration announced it will soon launch registration forms for state-licensed medical marijuana manufacturing, distribution and testing businesses that want to take advantage of federal protections under rescheduling—building on an existing form for dispensaries. The agency also recently updated its lists of controlled substances to formally note that marijuana subject to a state medical cannabis license falls under Schedule III. The Bureau of Alcohol, Tobacco, Firearms and Explosives posted draft revisions to a gun purchase form that would recognize medical marijuana’s federally legal status following the Trump administration’s rescheduling move. The Massachusetts legislature’s Special Joint Committee on Initiative Petitions recommended that lawmakers not act on a proposal to roll back the state’s marijuana legalization law, leaving prohibitionist activists to collect additional signatures to place it on the November ballot. Connecticut lawmakers sent Gov. Ned Lamont (D) a bill to expand a psychedelic pilot program to let all adults who meet eligibility criteria participate—instead of just veterans, retired first responders and healthcare workers—in anticipation of federal approval of psilocybin or MDMA. An Indiana Republican senator announced plans to file a bill to legalize medical cannabis in the 2027 session in light of Gov. Mike Braun’s (R) recent comments on the issue and as reform advances at the federal level under the Trump administration. Historian Emily Dufton highlights in a new Marijuana Moment op-ed how the Trump administration’s cannabis rescheduling move is focused on helping ailing seniors, but says she’s “concerned that this project was rolled out quickly with vocal support but little coordination.” “The rush to provide senior citizens with medical marijuana will require considerable legal, scientific and commercial infrastructures, which, in an ideal world, would avoid repeating historical mistakes by forming with clarity and coordination.” / FEDERAL President Donald Trump said his administration is “looking very seriously” at approving “natural 7-OH.” The Drug Enforcement Administration promoted an article about how “cannabis triggered one teen’s downfall from excelling at sports and having a bright future at college to suffering from a ‘God complex.'” / STATES Colorado regulators filed proposed changes to marijuana rules. Vermont regulators published guidance on cannabis cultivation tier increases. Ohio officials are launching a public education campaign about “the health and safety risks of marijuana use.” New York cannabis regulators are extending the application deadline for the Community Grants Reinvestment Fund to May 21. New Jersey regulators sent a newsletter with updates on various cannabis issues. The Nevada Cannabis Advisory Commission’s Subcommittee on Taxation will meet on Thursday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL San Francisco, California is seeing a surge in arrests and citations for low-level drug crimes, but not for sales, under a crackdown championed by the mayor. / INTERNATIONAL The International Criminal Court unsealed an arrest warrant for a Philippine senator linked to that county’s bloody “war on drugs.” Pakistan’s Economic Coordination Committee approved additional funds for the Cannabis Control and Regulatory Authority. / SCIENCE & HEALTH A study found that “legalization reduces cannabis possession and sales arrests for White and Black populations, narrowing but not eliminating disparities,” that there are “spillover increases in hospitalizations involving cannabis and other illegal drugs,” that “spillovers on arrests, incarcerations, and crimes involving serious violent or property offenses are insignificant or even decrease” and that “other illegal drug sales arrests decrease across populations.” / BUSINESS Cannara Biotech Inc. completed its acquisition of Medican Organic Inc. Cronos Group Inc. reported quarterly net revenue of $45.2 million and a comprehensive loss of $3.3 million. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post DEA launching new cannabis business registration applications (Newsletter: May 12, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Outstanding article! I want people to know just how good this information is in your article. Your views are much like my own concerning this subject. I will visit daily your blog because I know. It may be very beneficial for me. login nagawin

Leave normality behind and indulge your desires in a night filled with passion and sensuality with an amazing partner who appreciates every moment you spend with one another, by using the trusted Delhi escort service for a romantic rendezvous. Dhaula Kuan Escorts Service | Dilshad Garden Escort | Escort in East of Kailash | Golf Course Road Escorts | Escorts in Prithviraj Road |

Our agency delivers exclusive companionship services with a commitment to comfort, trust, and customer satisfaction. We carefully manage every interaction to ensure clients feel relaxed and valued throughout the experience. Choosing an Escort in Ashok Vihar through us means receiving dependable and professionally managed companionship assistance.

The sensual moves you will experience with the Female Call Girl Lucknow are incredibly exciting and alluring. You might be unaware of these girls' acts and maneuvers if you've never been to a tantalizing encounter with an independent woman.